Outline

• Terminology

• Bioequivalence

• Scenarios with antiretroviral drugs

  • New formulations
  • Alternative dosing regimens
  • Drug interactions
  • Dosing pediatric patients

• PK/PD Considerations

• Standard of Evidence

Previous slide

Next slide

Back to first slide

View graphic version